We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at ...

We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $25.0 to $70.0 for Moderna over the recent three months. In terms of liquidity ...

Citi analyst Geoff Meacham reiterated a Hold rating on Moderna (MRNA – Research Report) yesterday and set a price target of $40.00. The ...

Before joining Moderna, Cronin spent close to 20 years at Ogilvy, working within its global healthcare department in ...

"There will not be any research funded by NIH on mRNA vaccines," the scientist in New York similarly told the outlet. "MAGA ...

Scientists say that officials from the National Institutes of Health urged them to remove references to mRNA vaccine ...

In this article, we are going to look at where Moderna, Inc. (NASDAQ:MRNA) stands against other biotech stocks. The biotechnology sector is gaining new momentum with better market conditions ...

Delving into the details, we found 40% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we ...

In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer discusses. During the most recent episode of Mad Money, Jim Cramer ...